S. 1302 — 119th Congress
Federal bill
Increasing Transparency in Generic Drug Applications Act
- Title
- Increasing Transparency in Generic Drug Applications Act
- Type
- Senate bill
- Congress
- 119th Congress
- Chamber of origin
- Senate
- Introduced
- 2025-04-03
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Latest action date
- 2025-04-03
Organizations that named this bill in federal lobbying filings
- MASSACHUSETTS MEDICAL SOCIETY Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- MASSACHUSETTS MEDICAL SOCIETY cited in the filing's issue text 2 filings